193 related articles for article (PubMed ID: 19570458)
1. [Relationship of adiponectin and visfatin with fetus intrauterine growth].
Shang LX; Tang QL; Wang J; Zhang F; Wu N; Wang SH; Li P
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):246-8. PubMed ID: 19570458
[TBL] [Abstract][Full Text] [Related]
2. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
Zhang P; Liu B; Li G; Wu L; Yu M; Ou Y; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
[TBL] [Abstract][Full Text] [Related]
3. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia.
Wang J; Wang SH; Shang LX; Dong X; Wang X; Zhang F; Wu N; Xu LM; Ye YY
J Obstet Gynaecol Res; 2010 Jun; 36(3):533-7. PubMed ID: 20598033
[TBL] [Abstract][Full Text] [Related]
4. [Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].
Yang YD; Zhai GR; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):646-51. PubMed ID: 21092542
[TBL] [Abstract][Full Text] [Related]
5. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
[TBL] [Abstract][Full Text] [Related]
6. Perinatal circulating visfatin levels in intrauterine growth restriction.
Malamitsi-Puchner A; Briana DD; Boutsikou M; Kouskouni E; Hassiakos D; Gourgiotis D
Pediatrics; 2007 Jun; 119(6):e1314-8. PubMed ID: 17502346
[TBL] [Abstract][Full Text] [Related]
7. Relationship of adiponectin and resistin levels in umbilical serum, maternal serum and placenta with neonatal birth weight.
Wang J; Shang LX; Dong X; Wang X; Wu N; Wang SH; Zhang F; Xu LM; Xiao Y
Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):432-8. PubMed ID: 21039376
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1 in fetal serum correlates with insulin-like growth factor-I and fetal growth.
Ostlund E; Tally M; Fried G
Obstet Gynecol; 2002 Sep; 100(3):567-73. PubMed ID: 12220780
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies.
Roth S; Abernathy MP; Lee WH; Pratt L; Denne S; Golichowski A; Pescovitz OH
J Soc Gynecol Investig; 1996; 3(2):78-84. PubMed ID: 8796812
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factors, their binding proteins, and fetal macrosomia in offspring of nondiabetic pregnant women.
Wiznitzer A; Reece EA; Homko C; Furman B; Mazor M; Levy J
Am J Perinatol; 1998 Jan; 15(1):23-8. PubMed ID: 9475683
[TBL] [Abstract][Full Text] [Related]
12. Cord serum visfatin at term birth: maternal smoking unmasks the relation to foetal growth.
López-Bermejo A; de Zegher F; Díaz-Silva M; Vicente MP; Valls C; Ibáñez L
Clin Endocrinol (Oxf); 2008 Jan; 68(1):77-81. PubMed ID: 17681025
[TBL] [Abstract][Full Text] [Related]
13. Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations.
Stadler M; Storka A; Theuer EA; Krebs M; Vojtassakova E; Nowotny P; Pacini G; Kästenbauer T; Luger A; Prager R; Wolzt M; Anderwald C
Clin Endocrinol (Oxf); 2010 Jun; 72(6):763-9. PubMed ID: 19769621
[TBL] [Abstract][Full Text] [Related]
14. The relationship between serum visfatin, adiponectin, and insulin sensitivity markers in neonates after birth.
Meral C; Cekmez F; Pirgon O; Asya Tanju I; Metin Ipcioglu O; Karademir F; Gocmen I
J Matern Fetal Neonatal Med; 2011 Jan; 24(1):166-70. PubMed ID: 20486883
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function.
Fasshauer M; Blüher M; Stumvoll M; Tönessen P; Faber R; Stepan H
Clin Endocrinol (Oxf); 2007 Mar; 66(3):434-9. PubMed ID: 17302880
[TBL] [Abstract][Full Text] [Related]
16. Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of life.
El Shemi MS; Mohamed MH; AbdelRahman AO; Abdel Al H; Ramadan NM
J Neonatal Perinatal Med; 2016; 9(1):73-82. PubMed ID: 27002258
[TBL] [Abstract][Full Text] [Related]
17. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth.
Ibáñez L; Sebastiani G; Lopez-Bermejo A; Díaz M; Gómez-Roig MD; de Zegher F
J Clin Endocrinol Metab; 2008 Jul; 93(7):2774-8. PubMed ID: 18460569
[TBL] [Abstract][Full Text] [Related]
18. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
19. First-trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction.
Valdés ER; Lattes KA; Muñoz HS; Barja PY; Papapietro KV
Gynecol Obstet Invest; 2011; 72(3):152-6. PubMed ID: 21912074
[TBL] [Abstract][Full Text] [Related]
20. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
